Blog
Announcing IPC’s New Leadership for 2025.
Welcome the newest leadership to the IPC Board of Directors! Meet incoming IPC President Bruce Strober, Vice…
Welcome the newest leadership to the IPC Board of Directors! Meet incoming IPC President Bruce Strober, Vice…
Read MoreINTERNATIONAL FEDERATION OF PSORIASIS ASSOCIATION CONFERENCE (IFPA) | STOCKHOLM, SWEDEN Friday, June 28 17:45 - 18:45…
Generalized pustular psoriasis(GPP)lacks internationally accepted definitions and diagnostic criteria, impeding timely…
View ReportJoin Dr. Claudia de la Cruz, a dermatologist from Santiago, Chile, and Secretary of the International Psoriasis…
Read MoreIPC stands for accessible treatment and universal healthcare on World Psoriasis Day and beyond. Gain insights from…
Read MoreDiscover the latest updates on psoriasis from the World Congress of Dermatology (WCD) 2023, hosted in Singapore from…
Read MoreDiscover the latest updates on psoriasis from the World Congress of Dermatology (WCD) 2023, hosted in Singapore from…
View ReportDr. Claudia de la Cruz discusses the recent advances in the management of scalp psoriasis. La Dra. Claudia de la…
Watch VideoThe patient perspective has become even more important in the wake of the pandemic. Here’s how Clinica Dermacross is…
Read MoreREUNIÓN ANUAL DE DERMATÓLOGOS LATINOAMERICANOS (RADLA) | CURITIBA, BRAZIL Friday, May 26 14:00 – 17:00 BRT 13:00…
El Dra. de la Cruz analiza por qué es importante que los médicos vean la psoriasis desde la perspectiva del paciente…
Watch VideoDr. de la Cruz discusses why it’s important for physicians to view psoriasis from the patient’s perspective and how…
Watch VideoWORLD CONGRESS OF DERMATOLOGY (WCD) | SINGAPORE Monday, July 3 14:30 - 17:30 SGT Program chairs: Claudia de la…
La XXXIX Reunión Anual de Dermatólogos Latinoamericanos (RADLA) se realizó de manera virtual del 2 al 5 de mayo,…
Read MoreThe 4th webinar in the series will center around the organization of psoriasis clinics now and in the future, including…
Watch VideoIPC's newly appointed appointed officers take their roles beginning January 1, 2022.
Read MoreBiologics and biosimilars have created many new options in psoriasis treatment for patients worldwide, but patients…
Read MoreView Report
The introduction of biological drugs for the treatment of patients with psoriasis has revolutionized treatment…
View Report| Cookie | Duration | Description |
|---|---|---|
| cookielawinfo-checkbox-analytics | 11 months | This cookie is set by GDPR Cookie Consent plugin. The cookie is used to store the user consent for the cookies in the category "Analytics". |
| cookielawinfo-checkbox-functional | 11 months | The cookie is set by GDPR cookie consent to record the user consent for the cookies in the category "Functional". |
| cookielawinfo-checkbox-necessary | 11 months | This cookie is set by GDPR Cookie Consent plugin. The cookies is used to store the user consent for the cookies in the category "Necessary". |
| cookielawinfo-checkbox-others | 11 months | This cookie is set by GDPR Cookie Consent plugin. The cookie is used to store the user consent for the cookies in the category "Other. |
| cookielawinfo-checkbox-performance | 11 months | This cookie is set by GDPR Cookie Consent plugin. The cookie is used to store the user consent for the cookies in the category "Performance". |
| viewed_cookie_policy | 11 months | The cookie is set by the GDPR Cookie Consent plugin and is used to store whether or not user has consented to the use of cookies. It does not store any personal data. |
IPC Jr. Councilor Towhida Noor reviews the psoriasis pipeline: selective TYK2 inhibitors, long-acting IL-17 and IL-23 biologics, and IL-36 blockade in GPP.
IPC Board Member and Treasurer Joel Gelfand, MD, MSCE, is the editor of a new textbook, Psoriasis: An Expert Global Perspective, now available for preorder from Elsevier. He worked with associate editors IPC President Bruce Strober, MD, PhD; IPC Vice President/President-Elect Claudia de la Cruz, MD; and IPC Chief Medical Officer Peter van de Kerkhof, MD, PhD. Nearly 50 authors from 20 countries contributed 30 chapters covering psoriasis from its earliest descriptions through genetics, immunology, and current therapies, with clinical images of psoriasis across diverse skin tones. All royalties support IPC.
PRE-ORDER YOUR COPY
In this video, IPC Councilor Rodrigo Garcia Salinas, MD, a rheumatologist from Argentina, explains how to recognize psoriatic arthritis early, including why joint pain, how long a patient has had psoriasis, and family history can matter more than skin severity alone. He also reviews how imaging helps catch early disease and how to choose treatment based on each patient’s joint, spine, and skin involvement.
IPC President Bruce Strober reviews the link between psoriasis and metabolic disease, drawing on findings from IPC’s recent paper in the Journal of the American Academy of Dermatology (JAAD). He translates this growing body of evidence into five concrete priorities from the 2025 IPC Think Tank for improving cardiometabolic screening and care.